Enlightenment Awaits at Paris ESC Heart-Failure Sessions Enlightenment Awaits at Paris ESC Heart-Failure Sessions
Planned for the meeting in La Ville Lumi è re: Fresh insights on the TRUE-AHF, RELAX-AHF-2, and PARADIGM-HF trials, ICDs in nonischemic disease, and how empagliflozin may have earned its CV indication.Heartwire from Medscape
CONCLUSION: In this study assessing atherectomy in obese patients, OA and RA demonstrated comparable outcomes with complication rates within an acceptable range. It demonstrates that OA and RA can be safely performed in this high-risk patient subset with CAC. PMID: 30318482 [PubMed - as supplied by publisher]
Incidence of congestive heart failure 31 percent among women with a history of cardiotoxicity
Conditions: Heart Failure; Congestive Heart Failure Interventions: Device: Alexa+; Other: Standard of Care Arm Sponsors: Medstar Health Research Institute; National Institutes of Health (NIH); Georgetown-Howard Universities Center for Clinical and Translational Science; ObEN Artificial Intelligence Not yet recruiting
Publication date: Available online 16 October 2018Source: Canadian Journal of CardiologyAuthor(s): Nowell M. Fine, Yinong Wang, Aneal KhanAbstractA 54-year-old man with the lysosomal storage disorder Anderson-Fabry Disease (AFD) with cardiac involvement was placed on amiodarone for treatment of symptomatic paroxysmal atrial fibrillation. Shortly following he developed symptoms of acute decompensated heart failure requiring admission to hospital. Endomyocardial biopsy demonstrated findings consistent with AFD and possible amiodarone toxicity. Amiodarone was discontinued and the patient’s heart failure resolved with re...
Daniel M. Johnson, Gudrun Antoons
The American College of Cardiology Foundation and the American Heart Association recommend treating patients with heart failure with reduced ejection fraction (HFrEF) with the evidence-based beta blockers bisoprolol, carvedilol, and sustained-release metoprolol succinate(1) in order to reduce mortality and hospitalizations.(2 –6) To avoid triggering decompensation, treatment should begin with a low dose and then be uptitrated over time.(1) A report from an HF registry study conducted from 2003 - 2004 that was designed to improve adherence to treatment guidelines found that 75% of patients hospitalized for HFrEF were ...
Heart failure (HF) is associated with high morbidity and mortality, and is a major contributor to health care costs. Since the area continues to be rapidly evolving, the aim of this study was to examine 15-year trends in demographics, precipitants, symptoms and outcomes of patients hospitalised with HF, and consider the individual and societal implications.
Chronic heart failure is a complex and multifaceted syndrome characterised by an unpredictable trajectory, high symptom burden and reduced quality of life. Although palliative care is recommended, patient, provider and system factors limit access.
AbstractClinical impact of tissue protrusion (TP) after coronary stenting is still controversial, especially in patients with ST-segment elevation myocardial infarction (STEMI). A total of 104 STEMI patients without previous MI who underwent primary percutaneous coronary intervention (PCI) under intravascular ultrasound (IVUS)-guidance were included. Post-stenting grayscale IVUS analysis was performed, and the patients were classified according to the presence or absence of post-stenting TP on IVUS. Coronary angiography and single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI) with99mTc tetrof...
Anthracycline-exposed women should receive close cardiac surveillance during pregnancy Related items fromOnMedica Child cancer survivors can become pregnant as adults Breast cancer during pregnancy need not harm baby Include pregnant women in studies, urge researchers Heart failure with preserved ejection fraction